Strategies for Prescribing Aspirin to Prevent Preeclampsia: A Cost-Effectiveness Analysis

Obstet Gynecol. 2020 Jan;135(1):217. doi: 10.1097/AOG.0000000000003631.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aspirin*
  • Cost-Benefit Analysis
  • Female
  • Humans
  • Platelet Aggregation Inhibitors
  • Pre-Eclampsia*
  • Pregnancy
  • Risk Factors

Substances

  • Platelet Aggregation Inhibitors
  • Aspirin